🌿 SoapBox hemp
US LawReform & ChurchesFlower PricesSeeds & StrainsScienceLawData

Hemp & Cannabinoid Science / Product Formulation

Product Formulation

From refined extract to finished product: terpene reintroduction and strain-profile reconstruction, vape viscosity and crystallisation with cannabitriol treated as a working material, carriers and diluents ranked by route with the EVALI case told properly, edible dose uniformity, and deliberate CBN production as controlled oxidative aging.

5 pages · 54 citations (53 without a resolved identifier, marked on the page) · updated 2026-09-27

What this section is, and what it is not

Education and harm reduction. Not medical, legal or financial advice. Every factual claim carries a source; contested and single-source claims are marked as such on the page.

The boundary. This section teaches separation, purification, formulation, dosing arithmetic and analytical chemistry with real parameters, because withholding that detail from someone who will proceed anyway is the harm this library exists to prevent. It does not publish preparative routes for converting one cannabinoid into a more intoxicating one; those are described structurally and cited to the literature, without procedures.

Pages

Distillation strips the volatile fraction by design, which is why refined cannabinoid extract is potent and characterless. This page covers putting it back: inclusion rates by product type, miscibility and blending temperature, how a cultivar profile is rebuilt from a GC panel and what that reconstruction cannot recover, botanical versus cannabis-derived stocks, and where the flavour claim ends and the effect claim starts.
8 sections · tool
The vape-formulation engineering page. Why cannabinoid distillate is too thick and some cannabinoids crystallise in a cartridge, what that does to hardware, and the full toolkit for controlling it — with cannabitriol treated properly: its structure, its class, its known members, its occurrence and isolation history, and its established working use as an anti-crystallisation and viscosity-modifying agent. Where the published record on CBT is thin, this page says so and treats the gap as an open research question rather than as doubt about the material.
9 sections · cannabinoid
A material-by-material reference for everything a cannabinoid gets dissolved in or cut with, organised by route of administration rather than by chemistry — because the central fact is that a diluent qualified as food-safe has not thereby been qualified for inhalation, and the 2019 to 2020 EVALI outbreak is what that distinction costs when it is ignored.
9 sections · safety
Why a lipophilic active has to be carried in a fat phase or emulsified to be absorbed at all, what first-pass metabolism to 11-hydroxy-THC does to the dose-response relationship, and dose uniformity per unit as the one safety property an edible producer actually controls — with the arithmetic, the incorporation technique, the stability chemistry and the labelling consequences.
8 sections · safety
Cannabinol is the oxidative degradation product of Δ9-THC, formed by air, light, heat and time, so making it deliberately means running faster a reaction that is already happening in every badly stored jar. The same chemistry read one way is a storage-history readout on a certificate of analysis and read the other way is a product category — this page does both, and treats the marketed sedative claim as the thinly supported claim it is.
7 sections · cannabinoid
Absence is not safety. A substance or a pair that is not in this section was not checked and is not thereby safe. This is a curated mechanism reference built from primary literature and regulatory reference works — not a comprehensive interaction database, and not a substitute for a clinician or a pharmacist.